Zilucoplan (TFA)
Zilucoplan TFA (RA101495), a 15-amino acid macrocyclic peptide, is a potent complement component 5 (C5) inhibitor. Zilucoplan TFA can be used in research of immune-mediated necrotising myopathy (IMNM) [1][2].
Product Specifications
Product Name Alternative
RA101495 (TFA) ; RA3193 (TFA)
UNSPSC
12352209
Target
Complement System
Type
Peptides
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zilucoplan-tfa.html
Solubility
10 mM in DMSO
Smiles
CCCCCCCCCCCCCCCC(N[C@H](C(O)=O)CCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCC(NCCCC[C@H](NC([C@@H](NC([C@@H]1CCCN1C([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](N(C([C@@H]2CC(NCCCC[C@H](NC(C)=O)C(N[C@@H](C(C)C)C(N[C@@H](CCC(O)=O)C(N[C@@H](CCCNC(N)=N)C(N[C@@H](CC3=CC=CC=C3)C(N2)=O)=O)=O)=O)=O)=O)=O)C)CC(O)=O)=O)C(C)(C)C)=O)CC4=CC=C(O)C=C4)=O)CC5=CNC6=C5C=CC=N6)=O)CCC(O)=O)=O)CC7=CC=C(O)C=C7)=O)=O)C8CCCCC8)=O)C(O)=O)=O)=O)=O.OC(C(F)(F)F)=O.[x]
Molecular Formula
C172H278N24O55.xC2HF3O2
Molecular Weight
3562.18 (free base)
References & Citations
[1]Julien S, et, al. Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model. Biomedicines. 2022 Aug 20;10 (8) :2036.|[2]Gorman DM, et, al. Chemical synthesis and characterisation of the complement C5 inhibitory peptide zilucoplan. Amino Acids. 2021 Jan;53 (1) :143-147.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
Launched
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM2322-50 1x 50 µL
FAT1 (FAT atypical cadherin 1) (FAT1-3D7/1), 1mg/mL
Sign In for Pricing
View Details 
BNUB0896-500 1x 500 µL
PDCD1 / PD1 / CD279 (Programmed Cell Death 1) (NAT105), 0.2mg/mL
Sign In for Pricing
View Details